Clinical Research Committee Survey on Challenges of Conducting Surgical Trials Results

Similar documents
Bristol Hospital Cancer Care Center 2015 Annual Report

R E X C A N C E R C E N T E R. Annual Report Rex Cancer Care Committee 2012 On behalf of the Rex Cancer Center & Rex Health Care

Cancer treatment. TOP EUROPEAN CANCER EXPERTISE The path to recovery

Goals and Objectives: Breast Cancer Service Department of Radiation Oncology

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

Proton Therapy Center Czech

How To Know If You Have Cancer At Mercy Regional Medical Center

Breast Health Program

European Research Council

Our Facility. Advanced clinical center with the newest and highly exact technology for treatment of patients with cancer pencil beam

Lenox Hill Hospital Department of Surgery General Surgery Goals and Objectives

Targeted Therapy What the Surgeon Needs to Know

NCI Community Cancer Centers Program Program Overview Ascension Health St. Vincent Indianapolis Hospital

C a nc e r C e nter. Annual Registry Report

Case Number: RT (M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor

NEMICS Cancer Service Performance Indicator Audit Interim report 2014

Role of Robotic Surgery in Obese Women with Endometrial Cancer

Radiotherapy is involved in the treatment. Radiotherapy report sets new targets for Europe. Spotlighton...

The Center for Cancer Care. Comprehensive and compassionate care

Breast cancer research and a changing treatment pathway

GfK PURCHASING POWER INTERNATIONAL

Advances in Surgical Oncology

A comprehensive treatment and research center for people with brain tumors

Undergraduate -10months scolarship

ONCOLOGY NURSING 7 TH ESO-EONS MASTERCLASS IN March 2014 Ermatingen (Lake Constance) Switzerland MASTERCLASS

Pancreatic Cancer: FDA Approved Treatments and Clinical Trials

Principles of Radiation Therapy A Bapsi Chakravarthy, MD Associate e P rofessor Professor Radiation Oncology

Monitoring Clinical Stage to Improve Care

Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines

TRAINING IN SURGERY IN GREECE

Postgraduate Nursing Education in Europe and the Bologna Process

Advancing Health Economics, Services, Policy and Ethics. Reka Pataky, MSc ARCC Conference May 25, 2015

Treatment Algorithms for the Management of Lung Cancer in NSW Guide for Clinicians

How Oncology Nurses Use Evidence Based Practices in Patient Navigation

Breast. Patient information. cancer clinical pathway

Oncology Nurse Care Coordinators as. Navigators. Improving cancer disease management and the patient experience

CLINICAL ONCOLOGY MASTERCLASS IN April 2015 São Paulo, Brazil. Chairs: Scientific Co-ordinators: ESO - LATIN-AMERICAN PROGRAMME

La sopravvivenza dei tumori maligni nei confronti internazionali: anticipazione della diagnosi o modifica del decorso naturale della malattia?

Corso Integrato di Clinica Medica ONCOLOGIA MEDICA AA LUNG CANCER. VIII. THERAPY. V. SMALL CELL LUNG CANCER Prof.

There must be an appropriate administrative structure for each residency program.

Ask Us About Clinical Trials

Inova. Breast Care Institute

Current Status and Future Direction of Proton Beam Therapy

Health Science Career Field Allied Health and Nursing Pathway (JM)

Executive summary. What is proton radiotherapy?

at a critical moment Physician Suggestion Line...

Navigation and Cancer Rehabilitation

Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma

European Research Council

Adiuwantowe i neoadiuwantowe leczenie chorych na zaawansowanego raka żołądka

Guidance for Industry FDA Approval of New Cancer Treatment Uses for Marketed Drug and Biological Products

Clinical support roles in pediatric and neonatal settings across Europe

HOAG FAMILY CANCER INSTITUTE. Case for Support

Number. Source: Vital Records, M CDPH

THE BELMONT HEALTH CENTRE (Dr. J J Wijeratne & Partners) Patient Participation Report

Your Certified Professional Cancer Coach. An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer

Stage IV Renal Cell Carcinoma. Changing Management in A Comprehensive Community Cancer Center. Susquehanna Health Cancer Center

Division of Cancer Surgery Information Guide

THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS

Best of San Antonio Breast Cancer Symposium

No. prev. doc.: 8770/08 SAN 64 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008

The Center for Prostate Cancer. Personalized Treatment. Clinical Excellence.

The Science behind Proton Beam Therapy

Radiotherapy in Hungary: present status and future needs. Tibor Major, PhD National Institute of Oncology Radiotherapy Department Budapest, Hungary

Mesothelioma. 1. Introduction. 1.1 General Information and Aetiology

The University of Hong Kong Department of Surgery Division of Esophageal and Upper Gastrointestinal Surgery

RESEARCH EDUCATE ADVOCATE. Just Diagnosed with Melanoma Now What?

Singapore Cancer Registry Annual Registry Report Trends in Cancer Incidence in Singapore National Registry of Diseases Office (NRDO)

Complementary and alternative medicine use in Chinese women with breast cancer: A Taiwanese survey

Master Online Study Oncology. Study part time team up internationally!

Cancer in Ireland 2013: Annual report of the National Cancer Registry

Cancer Services for Adults and Children

Goals and Objectives Pediatric Surgery PGY 1 MCVH

2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)

Protein kinase C alpha expression and resistance to neo-adjuvant gemcitabine-containing chemotherapy in non-small cell lung cancer

Avastin in breast cancer: Summary of clinical data

COST Presentation. COST Office Brussels, ESF provides the COST Office through a European Commission contract

The Cancer Patient Journey. Dr. Jaco Fourie

Survivorship Care Plans Guides for Living After Cancer Treatment

Cancer incidence and mortality in Europe, 2004

Malignant Mesothelioma: an Update

Avastin in breast cancer: Summary of clinical data

HEALTHCARE PROFESSIONALS: NEW CHALLENGES, NEW SKILLS.

Department of Anesthesia & Perioperative Medicine 5-Year Strategic Plan FY Contents

COMMISSIONING. for ULTRA-RADICAL SURGERY ADVANCED OVARIAN CANCER

Small Cell Lung Cancer

A Career in Pediatric Hematology-Oncology? Think About It...

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

Example 1 is the Chart Audit Form. A few comments about the items are:

Evaluation Process and Performance Measurement in Health Care

TITLE: Comparison of the dosimetric planning of partial breast irradiation with and without the aid of 3D virtual reality simulation (VRS) software.

Carcinoma of the Cervix. Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology

Health Information. Technology and Cancer Information Management. Health Information Technology & Cancer Information Management 363

Foundations of Oncology Nursing Practice

Preliminary Program 9th EDS Postgraduate Course Riga, Latvia May 14-16, 2015

Specific Standards of Accreditation for Residency Programs in General Surgery

2014 Report of Cancer Program Activities for 2013

The Path Forward. International Women s Day 2012 Global Research Results

Table 2.2. Cohort studies of consumption of alcoholic beverages and cancer in special populations

Table of Contents. Data Supplement 1: Summary of ASTRO Guideline Statements. Data Supplement 2: Definition of Terms

Transcription:

Clinical Research Committee Survey on Challenges of Conducting Surgical Trials Results

SURVEY RESULTS Survey population = 3500 Total responses as of 24 August 2015 = 195 Response rate = 5.6% ESSO Clinical Research Committee survey Ge nd e r: Answe r Op tio ns Male Female Pe rce nt Co unt 82.5% 156 17.5% 33 a nswe re d q ue stio n skip p e d q ue stio n 189 6

Age range 25,0% 20,0% 15,0% 10,0% 25-30 31-35 36-40 41-45 46-50 51-55 56-60 61-65 66-70 over 70 5,0% Click 0,0% to edit Master subtitle style

Participating countries in the survey One response each Bangladesh Bosnia and Herzegovina COLOMBIA Croatia Denmark Finland Gangnam-gu IRAQ Ireland Lithuania Pakistan Russia Scotland, UK Slovakia Sweden Switzerland Turkey Ukraine VENEZUELA Yemen Russia

50,0% Type of practice 40,0% 30,0% 20,0% 10,0% 0,0% Academic University Private practice Mixed ESSO Clinical Research Committee survey Is sup p o rt a va ila b le fo r multi-ce nte r clinica l re se a rch in yo ur institutio n/ho sp ita l? Answe r Op tio ns Yes No Pe rce nt Co unt 74.7% 136 25.3% 46 a nswe re d q ue stio n skip p e d q ue stio n 182 13

What are the obstacles in initiating or participating in a surgical trial? Please rank from 1 to 8 (1 being the most important obstacle) Others Lack of research facility/personnel to support research activity such as case report form completion Difficult to control surgical quality Difficult to do randomization Lack of interest (either due to personal reasons, career path, hospital policies) Lack of training in research methodology Lack of funding 0,00 1,00 2,00 3,00 4,00 5,00 6,00 Lack of time

Other reasons Research support Lack of specialized data entry Lack of cooperation of senior personnel No senior on same specialty Support and funding are great barriers. Difficult procedure for study start in lower Austria, work may only be performed within official working hours (48 per week per physician) lack of study nurse Lack of support from the institution Lack of relations with other institutions Lack of vision from hospital management (clinical production is considered much more important than (surgical) research) Patients Regulatory Relationship with Other disciplines Financial Scientific Informed consent by (medical) illiterate patients or other languages Lack of numbers in a small country with small recruitment for rare pathology Number of patients Volume of patients may be a problem Participants Some regulation relevant our legal system We are doing a clinical trial Risk to be sued Process of getting ethical approval too challenging Hospital has not own med ethic com and regulations and paperwork is rather time consuming/expensive and sometimes overregulated Ethical committee clearance for new or novel procedures Certain radiotherapists do not discuss the case during the multidisciplinary meeting at our institution before initiating radiotherapy but only during therapy, therefore excluding any possibility of proposing surgery. A therapeutic decision has often been made in an other institution without consulting any surgeon. Many smaller tumors are being irradiated but could have been operated if discussed. Communication with other part Lack of relationship between colleagues Difficulties in collaboration with other specialties Have to practice to earn a living, no financial returns from research Lack of important genuine points of research Scarcity of worthwhile trials Author policy of major journals. To be in the middle of the author list does not match the effort seriously participating in those trials.

ESSO Clinical Research Committee survey W o uld yo u b e inte re ste d in p a rticip a ting in a sho rt tra ining co urse o n surg ica l clinica l re se a rch me tho d o lo g y? Answe r Op tio ns Yes No Pe rce nt Co unt 74.7% 133 25.3% 45 a nswe re d q ue stio n skip p e d q ue stio n 178 17 W o uld yo u co nsid e r this a s a n imp o rta nt a ctivity to initia te mo re surg ica l re se a rch? Answe r Op tio ns Yes No Pe rce nt Co unt 87.2% 157 12.8% 23 a nswe re d q ue stio n skip p e d q ue stio n 180 15 W o uld yo u o r yo ur ho sp ita l b e willing to p a y fo r this? Answe r Op tio ns Yes No Pe rce nt Co unt 41.6% 74 58.4% 104 a nswe re d q ue stio n 178 skip p e d q ue stio n 17

Would you be willing to participate in a prospective surgical clinical research? Yes (non-randomized only) Yes (non-randomized and randomized controlled trials) No ESSO Clinical Research Committee survey W o uld yo u like to b e p a rt o f the ESSO/EORT C surg ica l ne two rk fo r clinica l re se a rch? Answe r Op tio ns Yes No Pe rce nt Co unt 93.5% 158 6.5% 11 a nswe re d q stio n 169 Click to skip edit p e d q uemaster stio n subtitle style 26

60,0% What is your main specialty? (several answers possible) 50,0% 40,0% 30,0% 20,0% 10,0% 0,0%

Surgery with translational research Which field/disease groups of surgical oncology would be the most interesting for you to do research on? Please rank the top 3 (1 is the highest) Others Sarcoma/GIST Peritoneal surgery Pancreas and Biliary Tract Lung Liver (primary/secondary) Head & Neck Genito-urinary Gynaecology Gastric Esophageal Colorectal Breast Brain 0,00 2,00 4,00 6,00 8,00 10,00 12,00 14,00

Please consider the below ideas for surgical research and rank them according to your interest (1 is the most interesting) Others Prospective registries Cost effectiveness / Health services studies Biomedical science trials / translational research / Basic research Pre-op and post-op management: prehabilitation programme Pre-op and post-op management: patient reported outcomes Pre-op and post-op management: QoL Pre-op and post-op management: ERAS and surgical nutrition Neoadjuvant and adjuvant therapy Comparison of surgical techniques or devices omparison of surgical techniques: standard versus extensive lymphadenectomy Comparison of surgical techniques: open versus laparoscopic 0,00 2,00 4,00 6,00 8,00 10,00 12,00

Others disease groups and research topics Melanoma skin Cancer Lung metastases Bone Metastased Endocrine Throid cancer Oncoplastic surgery Adjuvant surgery or not in pretreated patients Anatomy: fresh cadaver dissection Breast cancer related topics Conventional versus robotic surgery Emotional & psychological study for cancer pt. especially in gerontology age over 8th decade Enhancement of surgical skills Epidemiological research. Image guided surgery Impact reduction Molecular outcome prediction